Peter Kabos

11PUBLICATIONS
96CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical physicsMolecular targetsPredictive and prognostic markersHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 23, 2026
Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial.

|Nov 08, 2025
Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs.

Jessica Finlay-Schultz, Kiran Vinod Paul, Benjamin Erickson

|Aug 11, 2025
Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.

Richard D Baird, Begoña Bermejo de Las Heras, Manuel Ruiz-Borrego

|Jul 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Robert Wesolowski, Hope S Rugo, Jennifer M Specht

|Jan 07, 2025
Metabolic Switch in Endocrine Resistant Estrogen Receptor Positive Breast Cancer.

Heather M Brechbuhl, Amy Han, Kiran Vinod Paul

|Nov 03, 2023
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer.

Komal L Jhaveri, Meritxell Bellet, Nicholas C Turner

Pageof 2

Frequent Collaborators

3 joint publications

Heather M Brechbuhl

2 joint publications

Aditya Bardia

2 joint publications

Robert Wesolowski

2 joint publications

Nicholas Turner